Recombinant multi-species VAC14 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine VAC14 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a scaffold protein that is a component of the PIKfyve protein kinase complex. This complex is responsible for the synthesis of phosphatidylinositol 3,5-bisphosphate, an important component of cellular membranes, from phosphatidylinositol 3-phosphate. Mice lacking a functional copy of this gene exhibit severe neurodegeneration. Mutations in the human gene have been identified in patients with a childhood onset progressive neurological disorder characterized by impaired movement, dystonia, and striatal abnormalities. [provided by RefSeq, May 2017]
The Alternative Names of target: ArPIKfyve,D8Wsu151e,Protein VAC14 homolog,TAX1BP2,TRX,Tax1-binding protein 2,Tax1bp2,Trx,VAC14,Vac14,ingls

Target products collectionGo to VAC14 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP10251-Ag-1/ GM-Tg-hg-IP10251-Ag-2 Human VAC14 protein Human
GM-Tg-rg-IP10251-Ag-1/ GM-Tg-rg-IP10251-Ag-2 Rat VAC14 protein Rat
GM-Tg-mg-IP10251-Ag-1/ GM-Tg-mg-IP10251-Ag-2 Mouse VAC14 protein Mouse
GM-Tg-cynog-IP10251-Ag-1/ GM-Tg-cynog-IP10251-Ag-2 Cynomolgus/Rhesus macaque VAC14 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP10251-Ag-1/ GM-Tg-felg-IP10251-Ag-2 Feline VAC14 protein Feline
GM-Tg-cang-IP10251-Ag-1/ GM-Tg-cang-IP10251-Ag-2 Canine VAC14 protein Canine
GM-Tg-bovg-IP10251-Ag-1/ GM-Tg-bovg-IP10251-Ag-2 Bovine VAC14 protein Bovine
GM-Tg-equg-IP10251-Ag-1/ GM-Tg-equg-IP10251-Ag-2 Equine VAC14 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP10251-Ag-1/ GM-Tg-hg-IP10251-Ag-2; GM-Tg-rg-IP10251-Ag-1/ GM-Tg-rg-IP10251-Ag-2;
GM-Tg-mg-IP10251-Ag-1/ GM-Tg-mg-IP10251-Ag-2; GM-Tg-cynog-IP10251-Ag-1/ GM-Tg-cynog-IP10251-Ag-2;
GM-Tg-felg-IP10251-Ag-1/ GM-Tg-felg-IP10251-Ag-2; GM-Tg-cang-IP10251-Ag-1/ GM-Tg-cang-IP10251-Ag-2;
GM-Tg-bovg-IP10251-Ag-1/ GM-Tg-bovg-IP10251-Ag-2; GM-Tg-equg-IP10251-Ag-1/ GM-Tg-equg-IP10251-Ag-2
Products Name VAC14 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name VAC14
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine VAC14 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.